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http://www.occup-med.com/content/8/1/9CASE REPORT Open AccessHydrogen sulphide inhalational toxicity at a
petroleum refinery in Sri Lanka: a case series of
seven survivors following an industrial accident
and a brief review of medical literature
Mitrakrishnan Chrishan Shivanthan1*, Harshani Perera1, Saroj Jayasinghe1,2, Panduka Karunanayake1,2,
Thashi Chang1,2, Sujatha Ruwanpathirana1, Nilwala Jayasinghe1, Yamini De Silva1 and Dinushka Jayaweerabandara1Abstract: This case series details clinical observations in 7 survivors of accidental hydrogen sulphide inhalation
toxicity at a petroleum refinery in Sri Lanka. One survivor developed status epilepticus and severe neurotoxicity
whilst another survivor developed delayed respiratory failure; both patients required intensive care management.
One victim manifested mild bronchospasms in the immediate post-exposure period and another developed mild
perioral numbness 2 days following the exposure. A brief literature review explores the manifestations,
pathophysiology and available modalities of treatment of hydrogen sulphide inhalation toxicity.
Background: Hydrogen sulphide (H2S) is a highly toxic gas. Accidental deaths following H2S exposure is a known
hazard amongst petroleum workers exposed to by-products of refineries. Toxicity results mainly due to cellular
respiratory poisoning which impairs oxidative phosphorylation. The heart, brain and the lungs are the organs most
commonly affected in H2S inhalational toxicity leading to varied clinical presentations.
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Workmen engaged in repair work at an oil refinery in
Sri Lanka were accidentally exposed to toxic fumes fol-
lowing a leak in a pipeline in mid-November 2012.
Hydrogen sulphide is the primary established noxious ef-
fluent carried in the damaged pipes. Other toxic agents
have never been identified during prior analysis of effluent
gases by the chemical engineering department of the insti-
tution and therefore are either absent or of negligible
levels. The victims were exposed to hydrogen sulphide
fumes for a period of approximately 10 minutes before res-
cue was attempted. The concentration of hydrogen
sulphide in the vicinity of the accident or levels each indi-
vidual was exposed to were not measured.
The victims were immediately taken to hospital but
two were declared dead on admission. This case series
documents the clinical and laboratory observations in 7
of the workmen who survived toxic exposure to H2S* Correspondence: mcs627@gmail.com
1National Hospital of Sri Lanka, Colombo, Sri Lanka
Full list of author information is available at the end of the article
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distribution, and reproduction in any mediuminhalation. Blood hydrogen sulphide levels could not be
measured in the victims as the test is not available in the
health sector of Sri Lanka.Case 1
A 36-y-old male admitted to the emergency treatment
unit within 1 hour of H2S exposure was found to be un-
conscious with cyanosis, labored-breathing, broncho-
spasms and generalized muscle twitching. He developed
three genreralized tonic-clonic convulsions within a
period of 30 minutes. His arterial blood oxygen satur-
ation on pulse oximetry was 80% breathing air, while his
blood pressure was 80/50 mm Hg. He was resuscitated
with bag and mask ventilation with high flow oxygen
and nebulized with salbutamol and ipratropium brom-
ide. He developed frequent ventricular ectopics and runs
of bradycardia associated with hypotension, but these
responded to anti-arrhythmic drugs. Seizures were
treated with parenteral benzodiazepines. Additionally, he
was given a single dose of intravenous hydrocortisone
200 mg. Capillary plasma glucose was normal. Thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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found to be normal.
The specific antidote sodium nitrite was administered
within 15 minutes of admission, which was 90 minutes
post-exposure. Despite these measures, he developed
recurrent seizures, deepening unconsciousness and
decerebrate posturing. He was treated with parenteral
barbiturates, intubated and artificially ventilated with
100% oxygen.
He was noted to have multiple neurofibromas on his
body and his medical records confirmed a diagnosis of
neurofibromatosis with a history of epilepsy since child-
hood. He had been seizure-free for almost 5 years fol-
lowing supervised withdrawal of phenytoin sodium in
2008. He had had decompressive-neurosurgery in 2008
for cervical radiculo-myelopathy secondary to neuro-
fibromatosis. He was commenced on phenytoin sodium
and sodium valproate via the nasogastric tube in view of
recurrent decerebrate posturing. His pupils remained
pin point and reacted sluggishly to light. The plantar
reflexes were flexor. There were no focal neurological
signs. His lungs remained clear except for a few scattered
wheezes and he was in sinus rhythm.
By day 3 he had regained consciousness and was
extubated uneventfully. However, he had marked trun-
cal ataxia and a scanning dysarthria on recovery. These
were associated with dysdiadochokinesia, dysmetria and
intention tremor, but sans nystagmus. He also complained
of a mild left-sided hearing impairment of recent onset.
Routine haematological and biochemical investigations
including full blood count, liver function tests, renal pro-
file and inflammatory markers did not demonstrate any
abnormality.
An MRI of the brain done on day 5 failed to detect
any structural abnormality to account for the cerebellar
dysfunction and hearing loss. A pure tone audiogram
done on day 14 was normal.
His anti-epileptic drugs were reduced to phenytoin
monotherapy. His dysarthria and ataxia improved over
the following two weeks. He was discharged 20 days
after admission with residual mild-dysarthria and mild-
ataxia of a modified Rankin scale of 2. He continued to
have retrograde amnesia of events preceding the occupa-
tional accident.
Case 2
A 46-y-old male exposed to hydrogen sulphide fumes
while rescuing his colleagues presented on day 4 post-
exposure with worsening shortness of breath, dry cough
and noisy breathing. On examination, he was mildly dys-
pnoeic and had scattered wheezes in both lung fields
with no crepitations. His arterial blood oxygen satur-
ation on pulse oximetry was 98%. Cardiovascular exam-
ination was unremarkable.He had pre-exisiting bronchial asthma, hypertension
and diabetes mellitus. The asthma was controlled with
prophylactic daily inhaled corticosteroids and intermit-
tent inhaled salbutamol. He was a smoker (5 pack-years
to date).
A baseline chest radiograph on admission was unre-
markable. He had a neutrophil leukocytosis of 23X103/ul.
The other cell lines were normal.
He was administered oral steroids (1/mg/kg), theo-
phylline, co-amoxiclav and nebulized salbutamol and
ipratropium bromide. However, over the next 3 days his
condition deteriorated and he became very dyspnoeic.
His oxygen saturation on air was 88% with an arterial
oxygen tension of 60 mmHg; PaCO2 was 26 mmHg; and
bicarbonate was normal. ECG did not show any abnor-
malities. Biochemical investigations apart for hypomag-
nesemia (0.6 mmol/l) were normal. A review chest
radiograph did not show a cause for his acute respiratory
decompensation. He was admitted to the intensive care
unit and treated with high-flow oxygen, intravenous cef-
triaxone, intravenous magnesium sulphate, oral potas-
sium supplements and frequent nebulizations. However,
his arterial oxygen saturation further reduced requiring
non-invasive continuous positive airway pressure sup-
port with an FiO2 of 60%. His arterial oxygen saturation
improved to 97%. He was then administered 1000 mg of
methylprednisolone intravenously per day on 3 consecutive
days. On the following day, he developed T wave inversion
in inferior and lateral leads of his ECG, but cardiac en-
zymes and echocardiogram remained normal. He gradually
improved over the ensuing days and was weaned off the
ventilator day 7 post-admission. A subsequent HRCT of
the chest did not show any abnormality. He was discharged
from hospital 5 days later, with a diagnosis of late chemical
pneumonitis and hypoxic cardiac ischaemia following
hydrogen sulphide inhalational toxicity.
Case 3
A 40-year-old male presented in the immediate post-
exposure period with bronchospasms without evidence
of hypoxia. He was administered nebulized salbutamol
and ipratropium bromide, and intravenous hydrocorti-
sone. His haematological and biochemical tests, ECG,
and chest radiograph were normal. His oxygen satur-
ation remained stable. He was discharged 3 days post-
exposure without further sequelae.
Case 4
A previously well male developed peri-oral numbness on
day 3 post-exposure. He had not had features of acute
toxicity. General and systemic examinations were nor-
mal. Chvostek and Trousseau signs were both negative.
Biochemical tests including serum ionized calcium, mag-
nesium, routine haematological tests, chest radiograph
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ing admission.
Case 5 to 7
Three exposure victims did not develop any clinical or
laboratory features of toxicity. They had inhaled only
small amounts of the leaked H2S fumes during the occu-
pational accident.
Discussion
Hydrogen Sulphide (H2S) is a highly toxic, colorless gas
that is recognized by a pungent odour reminiscent of
‘rotten eggs’. It is used in several industries and is a
product of many industrial processes such as oil refining,
mining and rayon manufacture [1]. H2S originates
mainly during breakdown of organic matter under an-
aerobic conditions. Following inhalation, H2S dissociates
into free sulphide and hydrogen ions in the blood circu-
lation. Sulphide binds to many macromolecules, includ-
ing cytochrome oxidase thereby preventing oxidative
phosphorylation. This causes reversible inhibition of aer-
obic metabolism leading to cellular anoxia [2,3].
Accidental deaths following accidental H2S exposure is
a known hazard amongst petroleum workers [4]. H2S
has also been implicated in deaths in farms following
slurry or manure related accidents [5].
The development of seizures in case 1 is of consider-
able interest. It could be due to the seizure threshold
being reached due to irritant effects of anoxia or due to
effects of H2S itself. H2S has been known to character-
istically cause sudden loss of consciousness which is
colloquially termed 'knockdown' [3,6]. Coma is often
associated with severe poisonings by H2S [7]. Recent
studies have shown that neurons have relatively high
H2S levels that act as messengers and therefore H2S is
a neuromodulator [8]. Animal studies indicate that this
neuromodulation includes up-regulation and increased
expression of gamma-aminobutyric acid B receptor sub-
units 1 (GABA(B)R1) and 2 (GABA(B)R2) [9]. However,
since GABA has inhibitory effects on neurons, one
would not expect H2S to reduce the seizure threshold
[10]. Therefore our patient probably developed seizures
as a consequence of the combination of hypoxic and
histotoxic hypoxia in the background of a propensity
for seizures, rather than a direct toxic effect of H2S.
Post-anoxic neurological sequelae have been reported
[6]. Survivors have been reported to exhibit neuro-
behavioral effects following acute, non-fatal H2S intoxi-
cation with proven reduction of cognitive capabilities,
depressive symptoms and personality changes even
though the results of neurological examination and neu-
roimaging techniques remained unremarkable [1]. A
case report detailing the sequelae following H2S expos-
ure in a 27-year-old male with Glasgow Coma Scorewhich improved from 3 to 15 over a 7 day period with
hyperbaric oxygen therapy showed that though both CT
and MRI of brain were unremarkable, PET scan 3 years
later showed abnormally decreased metabolism bilat-
erally in the temporal, inferior parietal lobes, left thal-
amus and abnormal uptake in the striatum. Further
cerebral perfusion studies showed bilaterally decreased
flow in the putamen without cortical abnormalities.
Neuropsychological and neurofunctional testing revealed
microsmia, psychomotor slowing, extrapyramidal signs
and deficits in memory and executive/planning function-
ing [11]. The primary effects of H2S may be confounded
by anoxia or head trauma [3]. Persistent vegetative state
is also a described phenomenon [6]. Subclinical and clin-
ical neuropsychiatric disorders have been documented to
manifest in the long-term in cases with exposure with-
out acute loss of consciousness [12]. A recent study car-
ried out in mice however demonstrated that when first
put into a suspended animation-like state by a 20-min
pretreatment with H2S followed by exposure to a hyp-
oxic environment survival is prolonged with no apparent
detrimental effects compared to mice which were not
pretreated with H2S. Hence H2S also has a propensity to
ameliorate hypoxic damage following exposure [13]
Studies have also demonstrated that H2S can induce a
hypometabolic, hibernation-like state in mammals when
given in subtoxic concentrations which will reduce the
demand for oxygen and minimize unavoidable hypoxia-
induced injury such as ischemia/reperfusion injury dur-
ing renal transplantation [14].
The features of central nervous system toxicity ob-
served in the patient 1 overlaps with previously docu-
mented features and pathophysiology of neurotoxicity
seen after hydrogen sulphide inhalation which are de-
scribed above. New onset cerebellar dysfunction though
unique to this patient could probably be explained by
cytotoxic hypoxic injury to neurons. Despite the pre-
existing neurofibromatosis and past history of seizures
controlled by antiepileptics the temporal relationship to
hydrogen sulphide exposure clearly establishes a cause
and effect link between the abnormality and the toxic
agent. PET scanning was not performed on our patient
due to financial constraints despite literature evidence of
studies showing abnormalities on PET imaging which
were undetectable on MRI and CT scanning. Early ad-
ministration of antidote and ventilation with 100% oxy-
gen is likely to have minimized the severity of hypoxic
damage. Persistent retrograde amnesia could either a
post traumatic event or more likely the result of hypoxic
damage to neurons involved in the complex tasks of
processing memories.
The delayed onset respiratory failure seen in patient 2
is probably explained by a reactive airway dysfunction
syndrome for which he probably could have had a
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ing. The absence of radiological evidence does not dis-
prove the entity as the pathology is one of airways rather
than gas exchange interface or alveolar parenchyma. Re-
sponse to steroids and ventilator support with high FiO2
with complete reversibility and the temporal relationship
to the exposure in this instance establish the relationship
between the phenomenon and the toxic agent. Hypo-
magnesemia is a new observation hitherto unreported
following hydrogen sulphide inhalation and is worth-
while looking for in future cases. Late onset perioral
numbness reported in one of the cases was not substan-
tiated by other clinical features of hypocalcemia or bio-
chemical investigations to suggest a disturbance of
calcium or magnesium homeostasis.
Animal studies following H2S poisoning have demon-
strated respiratory and circulatory changes as early as
10–15 minutes with 100% involvement in 20–25 minutes
in anaesthetized cats with severe respiratory disturbances
and abrupt decrease of mean systemic arterial pressure and
decreased cardiac output [15]. Studies in rats have demon-
strated morpho-functional alterations in the aero-hemic
barrier and surfactant system of the lungs with resultant
pulmonary oedema [16]. Acute respiratory failure caused
by an acute pulmonary oedema with left ventricular sys-
tolic dysfunction as a possible cause of this cardiorespira-
tory complication has been purported in medical literature
[7]. Exposure to higher concentrations increase the risk of
pulmonary oedema [3]. A late onset reactive airways dys-
function syndrome (RADS) after exposure to a high level of
toxic gases mainly hydrogen sulphide has been described in
a previously non-atopic man which had manifested with
moderate, partially reversible, airway obstruction and in-
creased responsiveness [17]. Hemorrhagic bronchitis and
pneumonitis have been demonstrated in postmortem stud-
ies and subacute lung injuries following long term exposure
to hydrogen sulphide has also been postulated [18].
Hydrogen sulphide induced mucosal irritation may
predominate at lower concentrations with a keratocon-
junctivitis called 'gas eye' [3] Animal model studies using
exfoliative cytology has yielded quantitative information
of value in ocular irritation studies [19].
Blood sulphide levels are useful in the diagnosis of
hydrogen sulphide toxicity and help to differentiate it from
others with a similar presentation. Delta aminolaevulunic
acid synthase and haem synthase levels are known to be
decreased following exposure to hydrogen sulphide; how-
ever no correlate could be drawn to levels of blood
sulphide in survivors [20].
Treatment following hydrogen sulphide toxicity is cur-
rently empirical, with a combination of nitrite and
hyperbaric oxygen [3,21,22]. 4-dimethylaminophenol has
also administered as an antidote, followed immediately
by hyperbaric oxygen therapy [2].The use of hyperbaric oxygen therapy (HBOT) for
H2S poisoning remains controversial, but has a similar
underlying rationale to that in carbon monoxide poison-
ing. HBOT may play a useful role in improving oxygen-
ation and acid–base status quickly and counteracting the
decrement in oxygen carriage caused by methaemoglo-
binaemia due to antidote administration [2].
Conclusions
The authors recommend measures to improve safety of
workers to minimize inhalational toxicity in situations
with possible hydrogen sulphide exposure. Vigilant
reporting of features of toxicity is needed in order to
collate the features of toxicity of this noxious gas. Anti-
dote use and hyperbaric oxygen therapy is beneficial in
cases with severe exposure and significant toxicity and
probably minimizes hypoxic tissue damage especially in
the central nervous system.
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